急性心肌梗死静脉溶栓治疗的疗效分析

Curative effect analysis of intravenous thrombolytic therapy in acute myocardial infarction

目的探讨分析静脉溶栓治疗早期急性心肌梗死的安全性及临床疗效。方法在心电监测下应用尿激酶静脉溶栓治疗93例急性心肌梗死患者,并对其临床资料进行回顾分析。结果 93例患者中冠脉达到再通标准69例,再通率为74.19%;24例未达再通标准,其中3例死亡,病死率为3.23%。发病<6 h溶栓治疗的成功率明显高于6～12 h的再通成功率,差异有统计学意义(P<0.05)。结论急性心肌梗死患者应尽早行静脉溶栓治疗,以减少并发症、降低病死率、提高再通的成功率。

Objective To observe the security and efficacy of intravenous thrombolytic therapy on acute myocardial infarction（AMT）. Methods Ninety-three patients with AMI were treated by intravenous thmmbolytie therapy of streptokinase under electrocardiogram monitoring and their results were analyzed. Results The coronary rccanalization were observed in 69 cases ,with a recanalization rates of 74. 19% and no recanalization was found in 24 cases. Of them 3 patients dided, with a mortality rate of 3.23%. The rates of reeanalization of thrombolytic therapy in 〈 6 h of onset group were significantly different higher than those in 6 - 12 h of onset group（P 〈 0.05）. Conclusion Early intravenous thrombolytic therapy to AMI can decrease the complication and mortality rate, increase the recanalization rates.